GDD/ID Flashcards

1
Q

Name 6 first tier metabolic investigations for IDD/GDD/ASD if red flags (CCMG 2022-2023)

A

If regression:
Ammonia, blood gase, lactate +/- lytes, AG (if seizures, LOC)
Plasma amino acids
Urine organic acids +/- mucopolysaccharides (if HSM, course facial feature)
Very long chain fatty acids
Total plasma homocysteine

Creatine panel (if hypotonia, movement disorders or seizures)
Copper, ceruloplasmin (if movement disorders)

CCMG - based on clinical presentation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the genetic test and indication for Rett Syndrome?

A

MECP2 testing
Mod-severe ID, clinical features (hand wringing, developmental regression and plateau consistent with Rett syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Name 2 additional genetic test to Fragile X and microarray for ID/GDD and their indication

A

MECP2 testing – moderate to severe ID, clinical features of Rett (hand wringing, developmental regression and plateau consistent with Rett syndrome)

Whole exome sequencing – if moderate to severe ID, syndromic features, negative first line testing

PTEN – macrocephaly if >98%ile, >2.5 SD

Karyotype – short stature, dysmorphic features

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diagnostic criteria for GDD

A
  • Delays >2 developmental domains (speech/language, social/personal, gross or fine motor, cognition, activities of daily living)  standard deviations below the mean with standardized tests
  • Children <5 yo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Diagnostic criteria for IDD

A

o Cognitive impairment in both clinical and standardized testing (FSIQ <70 +/-5)
o Deficit in adaptive functioning (limits in one or more activities of daily life: communication, social participation, independent living, across multiple environments) to the extend sufficient for ongoing support
o Onset in developmental period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Diagnostic yield of microarray in IDD/GDD?

A

8-20% by CPS
12-19% in mild, 20-30% in severe ID CCMG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List 6 benefits of identifying aetiology in GDD by microarray/CMA?

A

o Timely initiation of causal treatment or supportive management
o Prevention of complications
o Improved prognostication
o Accurate genetic counselling regarding recurrence risk, and prenatal/preimplantation genetic diagnosis when indicated
o Better access to services in the community
o Resolution of a diagnostic odyssey or avoidance of inappropriate, costly, and traumatizing tests

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

List 6 indications for MRI in IDD?

A
  • Micro/macrocephaly
  • Abnormal neurological exam (pyramidal/extra-pyramidal symptoms): Focal findings/ asymmetry, Abnormal tone, Abnormal movements (dystonia, chorea, athetosis, ataxia, rigidity…), Abnormal eye movements, Abnormal fundi
  • Developmental regression
  • Seizures
  • Altered LOC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

3 next steps in GDD/ID if microarray has non-specific findings or normal?

A
  1. Complete Tier 1 testing, consider Tier 2 testing
  2. Genetics referral
  3. Follow
  • MRI
  • Genetics referral for exome sequencing
  • Family testing if VUS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Level of functioning/prognosis by severity of IDD?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Name 5 differences between GDD and ASD in early development

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Name 3 single gene disorders associated with IDD ?

A

Fragile X (FMR1 gene with repeats), Rett syndrome (MECP2), Tuberous sclerosis (TSC1/2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

name 5 X-linked IDD syndromes

A

Fragile X
X linked adrenoleukodystrophy
Rett syndrome
MECP2 duplication syndrome
Lesch-Nyhan syndrome
Duchenne muscular dystrophy
OTC deficiency
Menkes disease
Alpha-thalassemia ID
Incontinentia pigmenti
Dyskeratosis congenita
Cornelia de lange – x linked dominant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Name 5 treatable IEM that cause GDD

A

Maple syrup urine disease
PKU
Homocysteinuria
Galactosemia
Biotinidase deficiency
Glutaric acidemia
Isovaleric acemia
Methymalonic acidemia
Citrin deficiency
Glutamine synthetase deficiency
OTC deficiency
X-linked adrenoleukodystrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Name 5 neurological features of IEM

A
  • Micro/macrocephaly
  • Hypotonia
  • Movement disorder – ie dystonia
  • Facial dysmorphisms
  • Sensory deficits – ie cataracts, retinopathy
  • Absent or brisk reflexes
  • Positive Babinski
  • Abnormal gait or inability to walk at developmental age
  • Cataracts
  • Abnormal smell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Name 5 non-neurological organ systems involved in IEM and the associated red flags

A

Body systems
- Hepatic
- Renal
- Pulmonary
- Cardiac
- Endocrine
- Visual
- Auditory
- Cutaneous
- Brain
- GI
- Reproductive

17
Q

3 possible trajectories in GDD?

A

o Ongoing developmental progress reaching average cognitive functioning
o Impaired developmental progress leading to intellectual disability or specific learning disorder
o Regression

18
Q

2 contraversies in the use of GDD

A

Delay implies ability to catch up whereas some children may be impaired and unable to catch up

Wide range of delays limited uniformity within the diagnosis - highly variable treatments

19
Q

what is the diagnostic yield of metabolic testing in GDD/ID?

A

1-5% (CPS)
0.25-0.42% (CCMG)

20
Q

What is the CMAJ opinion on screening for developmental delay ?

A

Does NOT improves health outcomes
Does NOT identify otherwise unrecognized cases
High FALSE POSITIVE rate
Minimal evidence for early intervention in developmental delays

Developmental surveillance (ongoing monitoring - identification of risk factors and elicitation of parental concerns) is recommended

21
Q

Clinical features of Fragile X

A
22
Q

Name 3 major groups of IEM and the associated clinical features & recommended investigations

A
23
Q

Which diagnosis are specifically associated with SLD in mathematics?

A
24
Q

4 things that you have to rule out to make a diagnosis of specific learning disorder.

A

Intellectual disability
visual impairment
auditory impairment
neurological disorder
mental disorder
psychosocial adversity
inadequate instruction

25
Q

Give two examples of aided, low-tech assisted and augmentative communication devices

A

“no tech”
motor behaviors, gestures, vocalizations, verbalizations (or verbal approximations), proxemics (approach or avoidance of a communication partner), eye gaze, and facial expressions, sign language

“low tech aided”
picture or object communication, the Picture Exchange Communication System (PECS), partner assisted scanning (e.g partner lists options)
“light Tech aided”: voice output communication systems which are typically battery operated and have a static (non-changing) display
Big Mac, Rocker Plate Talker, Step by Step, Cheaptalk, Tech Talk, Go Talk, Supertalker, or 7-Level Communication Builder.

“High Tech aided”: Systems typically requiring an electronic power source and having a dynamic (changing—i.e., computerized LCD screen) display
DynaVox Maestro, a Prentke Romich Accent, a Saltillo Nova-Chat or an iPad

26
Q

Name 5 things parents should know about his long-term outcomes for learning and independence. for mild IDD

A

Likely to live independently
· Support required with complex tasks like financial management
· Competitive, semi-skilled job without direct supervision
· Able to read (education level up to ~ grade 6)
· Ongoing difficulties with memory, abstract thinking, executive functioning

27
Q

Family that are refugees, 4yo child referred for developmental delay, but they don’t see anything wrong, list 6 reasons why families new to Canada may not report developmental concerns (6 Reasons why newcomer would not seek advice re: child with GDD)

A

lack awareness of typical child development.
not know about resources and systems to help children with developmental problems.
not know that governments and schools provide supports and accommodations for people with disabilities.
be reluctant to identify concerns, for fear of affecting their success in applying for permanent status.
may face challenges that make it difficult to act on the health care provider’s advice, such as lack of support systems, grief at what they have sacrificed, shame about their child’s disability

28
Q

What is the definition of GDD by the DSM-V

A